Skip to main content
Clinical Trials/NCT06115564
NCT06115564
Recruiting
Not Applicable

Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile Registry"

Azienda Unità Sanitaria Locale della Romagna1 site in 1 country200 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Jaundice, Obstructive
Sponsor
Azienda Unità Sanitaria Locale della Romagna
Enrollment
200
Locations
1
Primary Endpoint
Microbial assessment in patients undergoing to ERC with naive papilla
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The study is a prospective evaluation of the microbial assessment in patients undergoing to ERC with naive papilla; the population includes all the indication to biliary drainage.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Azienda Unità Sanitaria Locale della Romagna
Responsible Party
Principal Investigator
Principal Investigator

Carlo Fabbri

MD

Azienda Unità Sanitaria Locale della Romagna

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Microbial assessment in patients undergoing to ERC with naive papilla

Time Frame: July 2022 to 2023

Coltural assessment of the bile samples obtained pre- and post-sphincterotomy during ERC in naive papilla.

Secondary Outcomes

  • Check the presence of a possible association between specific biliary bacterial strains and definite pancreaticobiliary disorders.(July 2022 to 2023)
  • Identify potential differences in the pre sphincterotomy biliary microbial community depending on type of jaundice (benign or malignant).(July 2022 to 2023)
  • differences in the microbial community before and after sphincterotomy.(July 2022 to 2023)
  • MDR and sentinel germs detection(July 2022 to 2023)
  • Identify possible correlations between pre sphincterotomy positive biliary cultures, polymicrobial population and MDR organisms with several clinical features and with laboratory signs of acute cholangitis.(July 2022 to 2023)

Study Sites (1)

Loading locations...

Similar Trials